Novel Meso Drug Developed and Tested in Cambridge

Mesothelioma is notoriously one of the most aggressive and deadly forms of cancer. Most patients are given a year or only a few months to live after diagnosis. Despite these negative odds, some patients have managed to survive well past their life expectancy. One of the ways patients can often extend the duration and quality of life is through medication. Surgery is also an option, but doctors, patients, and researchers have acknowledged that there is still no cure.


A novel mesothelioma drug is being developed and tested on mesothelioma patients in Cambridge, Massachusetts. The development is a breakthrough for experts as well as patients who have been waiting for a treatment. According to reports, more than 107,000 people died from mesothelioma. Our Boston

Contact Information